Understand the source comparison
Best Selank Amidate Dosage Anxiety Reduction 2026: Clinical Comparison
300 mcg once daily 300 mcg Morning (30 min post-wake) 7–10 days Phase II trials (moderate) Effective for mild generalised anxiety. Requires consistent timing to maintain therapeutic window 300 mcg twice daily 600 mcg Morning + mid-afternoon (2–4 PM) 5–7 days P
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- 300 mcg once daily
- 300 mcg
- Morning (30 min post-wake)
- 7–10 days
- Phase II trials (moderate)
- Effective for mild generalised anxiety. Requires consistent timing to maintain therapeutic window
- 300 mcg twice daily
- 600 mcg
- Morning + mid-afternoon (2–4 PM)
- 5–7 days
- Phase III trials (strong)
- Gold standard protocol. Matches cortisol rhythm for maximum HPA axis modulation
- 300 mcg three times daily
- 900 mcg
- Morning + afternoon + evening
- Limited trial data
- Marginal benefit over BID dosing. Increased cost without proportional efficacy gain
- 600 mcg twice daily
- 1200 mcg
- Morning + afternoon
- Variable (5–14 days)
- Case reports only
- No controlled data supporting superiority. Receptor saturation likely limits additional effect
- The 300 mcg BID protocol (600 mcg daily total) represents the evidence-based standard for anxiety reduction based on reproducible trial outcomes and mechanism alignment with cortisol physiology.